New biomarker may help match cancer patients to the right therapy faster
NCT ID NCT05461430
First seen Nov 01, 2025 · Last updated May 26, 2026 · Updated 29 times
Summary
This study tested a new method to see if a biomarker called 'mass response' can predict how well a cancer patient will respond to a specific treatment. Researchers collected tumor cells from 72 adults with various cancers using fluid drainage or tissue biopsies. The goal was to validate whether this approach could help guide therapy decisions more quickly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
xCures
Oakland, California, 94612, United States
Conditions
Explore the condition pages connected to this study.